| Autor: |
Watanabe, Yukinobu, Ogawa, Masahiro, Tamura, Yu, Suda, Seiichiro, Kaneko, Masahiro, Kumagawa, Mariko, Hirayama, Midori, Matsumoto, Naoki, Yamamoto, Toshiki, Moriyama, Mitsuhiko |
| Zdroj: |
Journal of Investigative Medicine High Impact Case Reports; 11/30/2021, p1-4, 4p |
| Abstrakt: |
A 74-year-old man was diagnosed with hepatocellular carcinoma. The tumor in the liver showed a complete response after transcatheter arterial chemoembolization, but lung, bone, and lymph node metastases were observed, so treatment with atezolizumab plus bevacizumab was initiated. After administration, the scans showed tumor growth, but after continuous administration of atezolizumab plus bevacizumab, the tumors finally reduced in size and showed a partial response. The transient growth of the tumors was considered to be pseudoprogression. Herein, we report a case of pseudoprogression in hepatocellular carcinoma treated with atezolizumab plus bevacizumab. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
